Effectiveness of Recombinant Human Erythropoietin Therapy in Myelodysplastic Syndromes

J.W. Adamson,M. Schuster,S. Allen,N.R. Haley

Effectiveness of Recombinant Human Erythropoietin Therapy in Myelodysplastic Syndromes

1992

J.W. Adamson
M. Schuster
S. Allen
N.R. Haley

In an attempt to determine predictors of response to recombinant human erythropoietin (r-HuEPO) therapy in 20 patients with various subtypes of myelodysplastic syndrome (MDS), plasma concentrations of

Keywords:

Diabetes mellitus
Erythropoietin
Medicine
Immunology
Transferrin receptor
Erythropoietin therapy
Myelodysplastic syndromes
Recombinant DNA
plasma concentration

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations